Novel Biomarkers for Diagnosing Systemic Lupus Erythematosus Detected in Plasma
Researchers evaluated the clinical value of miR-124-3p and miR-337-3p in plasma to determine whether they could serve as biomarkers for systemic lupus erythematosus.
Researchers evaluated the clinical value of miR-124-3p and miR-337-3p in plasma to determine whether they could serve as biomarkers for systemic lupus erythematosus.
Researchers evaluated the pharmacodynamics and pharmacokinetics of oral iberdomide in patients with active systemic lupus erythematosus (SLE).
Researchers investigated the impact of time to remission, number of flares, and time on immunosuppressives after remission on estimated glomerular filtration rate in patients with lupus nephritis.
A second biopsy adds valuable information on lupus nephritis course, according to investigators.
Researchers investigated the seroreactivity of COVID-19 vaccination and adverse events among patients with systemic lupus erythematosus and rheumatoid arthritis.
Researchers investigated the choices and sequences of treatment strategies in children with juvenile systemic lupus erythematosus.
Researchers evaluated the prevalence and impact of cognitive impairment on quality of life in patients with SLE.
Researchers studied the relationship between the total burden of arterial plaque and cardiovascular disease risk in patients with systemic lupus erythematosus.
For patients with cutaneous lupus erythematosus, normal-appearing skin is a type I interferon-rich, prelesional environment.
Researchers assessed risk factors and characteristics of a pediatric population with discoid lupus erythematosus and systemic lupus erythematosus.